Hemang Jani suggests caution towards pure-play brokerage firms due to their F&O volume reliance, favoring wealth management companies like Nuvama and HDFC AMC. SBI’s QIP is viewed positively, while Tech Mahindra’s results were mixed, with communication segment showing promise. Glenmark’s recent surge makes it less attractive currently, but Aurobindo Pharma and Lupin are favored in the pharma sector.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets